Belviq (bel-VEEK, lorcaserin) will join Qsymia and other weight loss meds in the battle of the bulge

July 2013

Belviq (bel-VEEK, lorcaserin) will join Qsymia and other weight loss meds in the battle of the bulge.

Americans spend $60 billion a year trying to lose weight.

The health benefits are significant IF they succeed. Just a 5% to 10% drop in weight can improve blood pressure, lipids, and glucose.

Get concise advice on drug therapy, plus unlimited access to CE

Pharmacist's Letter membership benefits include:

12 issues every year — what you need to know and do, right now
Quick, practical reference charts and tools
Comprehensive CE library to meet license renewal and state requirements
Multiple course formats including live webinars, podcasts, and CE-in-the-Letter to match your learning style
Plus much more!

Choose the right tier for your needs today.

Already a subscriber? Log in

Volume pricing available. Get a quote